Our research finds that Life Sciences CEOs are confident in industry growth fueled by innovation, technological advancement, and operational efficiency. There is a strong appetite for mergers and acquisitions, substantial investments in AI and digitalisation, and a critical need to empower the workforce to navigate rapid change. While sustainability and ESG remain high on the agenda for Life Sciences organisations globally, there are shifting priorities across regions.
2025 Life Sciences CEO Outlook
Explore how leaders in the sector are navigating industry challenges and shaping their strategies for long-term success.
Key findings
Organisations that have already adapted their growth strategies due to interrelated challenges
Life sciences: 80%
Cross sector average: 72%
Why download the report?
By downloading the 2025 Life Sciences CEO Outlook, you’ll unlock unique perspectives on:
- Industry growth prospects and drivers, M&A appetite, and operational challenges
- AI and other capabilities investment
- Workforce challenges and transformation
- Evolution of ESG strategies
Enhance your strategic planning with expert analysis and actionable insights.
Our insights
Our people
Peter Liddell
Principal Advisor, Head of Healthcare and Life Sciences, and Global Leader, Operations Centre of Excellence
KPMG in Singapore